Identification of Immunodominant Neutralizing Epitopes on the Hemagglutinin Protein of Rinderpest Virus

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2002 Jan 19

PMID 11799164

Citations 7

Authors

Makoto Sugiyama

Naoto Ito

Nobuyuki Minamoto

Seiichi Tanaka

Affiliations

Soon will be listed here.

Abstract

The immunodominant epitopes on the hemagglutinin protein of rinderpest virus (RPV-H) were determined by analyzing selected monoclonal antibody (MAb)-resistant mutants and estimating the level of antibody against each epitope in five RPV-infected rabbits with the competitive enzyme-linked immunosorbent assay (c-ELISA). Six neutralizing epitopes were identified, at residues 474 (epitope A), 243 (B), 548 to 551 (D), 587 to 592 (E), 310 to 313 (G), and 383 to 387 (H), from the data on the amino acid substitutions of hemagglutinin protein of MAb-resistant mutants and the reactivities of MAbs against RPV-H to the other morbilliviruses. The epitopes identified in this study are all positioned on the loop of the propeller-like structure in a hypothetical three-dimensional model of RPV-H (J. P. M. Langedijk et al., J. Virol. 71:6155-6167, 1997). Polyclonal sera obtained from five rabbits infected experimentally with RPV were examined by c-ELISA using a biotinylated MAb against each epitope as a competitor. Although these rabbit sera hardly blocked binding of each MAb to epitopes A and B, they moderately blocked binding of each MAb to epitopes G and D and strongly blocked binding of each MAb to epitopes E and H. These results suggest that epitopes at residues 383 to 387 and 587 to 592 may be immunodominant in humoral immunity to RPV infection.

Citing Articles

Identification of a new polymorphism on the wild-type canine distemper virus genome: could this contribute to vaccine failures?.

Menezes K, Dabilla N, Souza M, Damasceno A, Torres B Braz J Microbiol. 2023; 54(2):665-678.

PMID: 37140816 PMC: 10235312. DOI: 10.1007/s42770-023-00971-x.

Phylogenetic evidence of the intercontinental circulation of a Canine distemper virus lineage in the Americas.

Duque-Valencia J, Forero-Munoz N, Diaz F, Martins E, Barato P, Ruiz-Saenz J Sci Rep. 2019; 9(1):15747.

PMID: 31673120 PMC: 6823503. DOI: 10.1038/s41598-019-52345-9.

Phylogenetic analysis of the wild-type strains of canine distemper virus circulating in the United States.

Anis E, Newell T, Dyer N, Wilkes R Virol J. 2018; 15(1):118.

PMID: 30068352 PMC: 6090796. DOI: 10.1186/s12985-018-1027-2.

Current perspectives on conventional and novel vaccines against peste des petits ruminants.

Liu F, Wu X, Liu W, Li L, Wang Z Vet Res Commun. 2014; 38(4):307-22.

PMID: 25224755 DOI: 10.1007/s11259-014-9618-x.

Genetic characterization of the Korean LATC06 rinderpest vaccine strain.

Yeh J, Kwoen C, Jeong W, Jeoung H, Lee H, An D Virus Genes. 2010; 42(1):71-5.

PMID: 21053063 DOI: 10.1007/s11262-010-0543-y.

References

Yamanouchi K . Comparative aspects of pathogenicity of measles, canine distemper, and rinderpest viruses. Jpn J Med Sci Biol. 1980; 33(2):41-66. DOI: 10.7883/yoken1952.33.41. View

Schrag S, Rota P, Bellini W . Spontaneous mutation rate of measles virus: direct estimation based on mutations conferring monoclonal antibody resistance. J Virol. 1998; 73(1):51-4. PMC: 103807. DOI: 10.1128/JVI.73.1.51-54.1999. View

Ishii H, Yoshikawa Y, Yamanouchi K . Adaptation of the lapinized rinderpest virus to in vitro growth and attenuation of its virulence in rabbits. J Gen Virol. 1986; 67 ( Pt 2):275-80. DOI: 10.1099/0022-1317-67-2-275. View

Yilma T, Hsu D, Jones L, Owens S, Grubman M, Mebus C . Protection of cattle against rinderpest with vaccinia virus recombinants expressing the HA or F gene. Science. 1988; 242(4881):1058-61. DOI: 10.1126/science.3194758. View

Makela M, Lund G, Salmi A . Antigenicity of the measles virus haemagglutinin studied by using synthetic peptides. J Gen Virol. 1989; 70 ( Pt 3):603-14. DOI: 10.1099/0022-1317-70-3-603. View

Makela M, Salmi A, Norrby E, Wild T . Monoclonal antibodies against measles virus haemagglutinin react with synthetic peptides. Scand J Immunol. 1989; 30(2):225-31. DOI: 10.1111/j.1365-3083.1989.tb01205.x. View

Sugiyama M, Minamoto N, Kinjo T, Hirayama N, Sasaki H, Yoshikawa Y . Characterization of monoclonal antibodies against four structural proteins of rinderpest virus. J Gen Virol. 1989; 70 ( Pt 10):2605-13. DOI: 10.1099/0022-1317-70-10-2605. View

Tsukiyama K, Yoshikawa Y, Kamata H, Imaoka K, Asano K, Funahashi S . Development of heat-stable recombinant rinderpest vaccine. Arch Virol. 1989; 107(3-4):225-35. DOI: 10.1007/BF01317919. View

Chou P, Fasman G . Prediction of protein conformation. Biochemistry. 1974; 13(2):222-45. DOI: 10.1021/bi00699a002. View

10.

Malvoisin E, Wild F . Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge. J Virol. 1990; 64(10):5160-2. PMC: 248009. DOI: 10.1128/JVI.64.10.5160-5162.1990. View

11.

Sugiyama M, Minamoto N, Kinjo T, Hirayama N, Asano K, Tsukiyama-Kohara K . Antigenic and functional characterization of rinderpest virus envelope proteins using monoclonal antibodies. J Gen Virol. 1991; 72 ( Pt 8):1863-9. DOI: 10.1099/0022-1317-72-8-1863. View

12.

Hu A, Sheshberadaran H, Norrby E, Kovamees J . Molecular characterization of epitopes on the measles virus hemagglutinin protein. Virology. 1993; 192(1):351-4. DOI: 10.1006/viro.1993.1042. View

13.

Liebert U, Flanagan S, Loffler S, Baczko K, Ter Meulen V, Rima B . Antigenic determinants of measles virus hemagglutinin associated with neurovirulence. J Virol. 1994; 68(3):1486-93. PMC: 236604. DOI: 10.1128/JVI.68.3.1486-1493.1994. View

14.

Hu A, Cattaneo R, Schwartz S, Norrby E . Role of N-linked oligosaccharide chains in the processing and antigenicity of measles virus haemagglutinin protein. J Gen Virol. 1994; 75 ( Pt 5):1043-52. DOI: 10.1099/0022-1317-75-5-1043. View

15.

Hummel K, Bellini W . Localization of monoclonal antibody epitopes and functional domains in the hemagglutinin protein of measles virus. J Virol. 1995; 69(3):1913-6. PMC: 188806. DOI: 10.1128/JVI.69.3.1913-1916.1995. View

16.

Sugiyama M, Minamoto N, Kinjo T, Ito H, Yamanouchi K . The nucleotide sequence of the hemagglutinin gene of the LA strain of rinderpest virus, a seed virus strain used for vaccine production in Japan. J Vet Med Sci. 1996; 58(8):769-71. DOI: 10.1292/jvms.58.769. View

17.

Ziegler D, Fournier P, Berbers G, Steuer H, Wiesmuller K, Fleckenstein B . Protection against measles virus encephalitis by monoclonal antibodies binding to a cystine loop domain of the H protein mimicked by peptides which are not recognized by maternal antibodies. J Gen Virol. 1996; 77 ( Pt 10):2479-89. DOI: 10.1099/0022-1317-77-10-2479. View

18.

Fournier P, Brons N, Berbers G, Wiesmuller K, Fleckenstein B, Schneider F . Antibodies to a new linear site at the topographical or functional interface between the haemagglutinin and fusion proteins protect against measles encephalitis. J Gen Virol. 1997; 78 ( Pt 6):1295-302. DOI: 10.1099/0022-1317-78-6-1295. View

19.

Langedijk J, Daus F, van Oirschot J . Sequence and structure alignment of Paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin. J Virol. 1997; 71(8):6155-67. PMC: 191876. DOI: 10.1128/JVI.71.8.6155-6167.1997. View

20.

Atabani S, Obeid O, Chargelegue D, Aaby P, Whittle H, Steward M . Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection. J Virol. 1997; 71(10):7240-5. PMC: 192064. DOI: 10.1128/JVI.71.10.7240-7245.1997. View